25.03.2013 Views

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

These contrasted with the conclusions drawn from the multicentre trial by Watson et<br />

al 109 who found that crude intervention group actuarial survival rates were marginally<br />

better yet of borderline statistical significance (unstated statistic, p = 0.08). Various<br />

stratification techniques uncovered highly statistically significant survival benefits for the<br />

intervention protocol in patients with stage III disease after controlling for centre effects<br />

(p = 0.009). The relevance of these post-hoc analyses is unknown but they are<br />

unsatisfactory when performed without substantial protection from increasing the<br />

probability of detecting a significant difference when none exists (Type I error).<br />

Fletcher et al 110 and Glassburn et al, 111 failed to detect statistically significant survival<br />

advantages between intervention and comparison groups (Table 70). The study by<br />

Johnson and Walton 112 selectively report the experience of a subset of participants<br />

without divulging the overall comparisons described in their methods section. The<br />

experience of 14 subjects assigned to the comparison group are undisclosed. If<br />

conservative assumptions are applied (ie, that all missing comparison group subjects<br />

died), then the intervention protocol is found to be statistically significantly associated<br />

with death over five years (p = 0.0449).<br />

Table 70 Outcomes following treatment for cervical cancer in intervention and comparison<br />

groups. 110,111<br />

Outcome<br />

Fletcher 1977<br />

Intervention Group Comparison Group p<br />

110<br />

Sample size (n)<br />

Five-year disease free survival (%)<br />

Glassburn 1974 111<br />

Sample size (n)<br />

27-month disease-free survival (%)<br />

Johnson 1974 112<br />

Sample size (n)<br />

Five-year disease-free survival (%)<br />

<strong>Hyperbaric</strong> oxygen therapy 71<br />

109<br />

33.0<br />

17<br />

41.1<br />

25<br />

44.0<br />

124<br />

41.1 0.2021<br />

23<br />

39.1 0.8961<br />

25<br />

16.0 0.0308<br />

Summary<br />

The studies failed to provide enough evidence to come to firm conclusions about the<br />

effectiveness of exposure to HBO in conjunction with radiotherapy for cervical cancer.<br />

Any conclusions reached from these studies would need to take into consideration the<br />

disparity in intervention and comparison protocols, poor methodological descriptions,<br />

and substantial post-hoc comparisons.<br />

Bladder cancer<br />

Four studies were retrieved from the published literature, and judged to meet inclusion<br />

and exclusion criteria (Table 71).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!